The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostication of survival from nasopharyngeal carcinoma by reduction of plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course: A new paradigm of prognostication.
Anthony T. C. Chan
No relevant relationships to disclose
Allen K.C. Chan
No relevant relationships to disclose
Brigette Ma
No relevant relationships to disclose
Edwin Pun Hui
No relevant relationships to disclose
Frankie Mo
No relevant relationships to disclose
Katherine Chow
No relevant relationships to disclose
Linda Leung
No relevant relationships to disclose
Ka Wah Chu
No relevant relationships to disclose
Benny C.Y. Zee
No relevant relationships to disclose
Dennis YM Lo
Consultant or Advisory Role - Sequenom
Stock Ownership - Sequenom
Sing Fai Leung
No relevant relationships to disclose